Portal:CPTAC/Hallmarks

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
Current revision (18:59, 5 October 2017) (view source)
(added Therapeutics category)
 
(7 intermediate revisions not shown.)
Line 1: Line 1:
-
{| style="margin: 10px; background-color:#eaf2ee"
+
{| style="width:100%; margin: 10px; background-color:#eaf2ee"
-
|width=100px; cell padding=50px; style="text-align:center;"|'''Sustaining proliferative signaling''' {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmarks/Proliferative}} View all [[Portal:CPTAC/Hallmark/Proliferative|hallmark pathways]]
+
|width=100px; cell padding=50px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Proliferative|<big><u><b>Sustaining proliferative signaling</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Proliferative}}
-
|width=100px; style="text-align:center;"|'''Evading growth suppressors'''{{#pwImage:Pathway:WP3972|250px||PDGFR-beta pathway}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Growth|<big><u><b>Evading growth suppressors</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Growth}}
-
|width=100px; style="text-align:center;"|'''Activating invasion and metastasis''' {{#pwImage:Pathway:WP2828|250px||Bladder Cancer}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Invasion|<big><u><b>Activating invasion and metastasis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Invasion}}
-
|width=100px; style="text-align:center;"|'''Enabling replicative immortality''' {{#pwImage:Pathway:WP581|250px||EPO Receptor Signaling}}
+
|-
|-
-
|width=100px|{{#pwImage:Pathway:WP673|250px||ErbB Signaling Pathway}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/immortality|<big><u><b>Enabling replicative immortality</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/immortality}}
-
|width=100px|{{#pwImage:Pathway:WP585|250px||Interferon type I signaling pathways}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Angiogenesis|<big><u><b>Inducing angiogenesis</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Angiogenesis}}
-
|width=100px|{{#pwimage:Pathway:WP3|250px||Transcriptional activation by NRF2}}
+
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Resisting|<big><u><b>Resisting cell death</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Resisting}}
-
|width=100px|{{#pwimage:Pathway:WP4018|250px||Pathways in Renal Cancer}}
+
|-
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Deregulating|<big><u><b>Deregulating cellular energetics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Deregulating}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Instability|<big><u><b>Genome instability and mutation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Instability}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Inflammation|<big><u><b>Tumor promoting inflammation</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Inflammation}}
 +
|-
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Avoiding|<big><u><b>Avoiding immune destruction</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Avoiding}}
 +
|width=100px; style="text-align:center;"|[[Portal:CPTAC/Hallmark/Therapeutics|<big><u><b>Therapeutics</b></u></big>]] {{ #pathwayOfTheDay: {{LOCALDAYNAME}} {{LOCALDAY}} {{LOCALMONTHNAME}} {{LOCALYEAR}} | Portal:CPTAC/Hallmark/Therapeutics}}
|}
|}

Current revision

Sustaining proliferative signaling

MAPK signaling (Homo sapiens)

Image does not exist
MAPK signaling
Evading growth suppressors

Tumor suppressor activity of SMARCB1 (Homo sapiens)

Image does not exist
Tumor suppressor activity of SMARCB1
Activating invasion and metastasis

MFAP5-mediated ovarian cancer cell motility and invasiveness (Homo sapiens)

Image does not exist
MFAP5-mediated ovarian cancer cell motility and invasiveness
Enabling replicative immortality

lncRNA in canonical Wnt signaling and colorectal cancer (Homo sapiens)

Image does not exist
lncRNA in canonical Wnt signaling and colorectal cancer
Inducing angiogenesis

MSMP expression regulation in cancer cells and its pro-angiogenic role in ovarian tumors (Homo sapiens)

Image does not exist
MSMP expression regulation in cancer cells and its pro-angiogenic role in ovarian tumors
Resisting cell death

miRNA regulation of p53 pathway in prostate cancer (Homo sapiens)

Image does not exist
miRNA regulation of p53 pathway in prostate cancer
Deregulating cellular energetics

Hereditary leiomyomatosis and renal cell carcinoma pathway (Homo sapiens)

Image does not exist
Hereditary leiomyomatosis and renal cell carcinoma pathway
Genome instability and mutation

ATM signaling (Homo sapiens)

Image does not exist
ATM signaling
Tumor promoting inflammation

Cytokines and inflammatory response (Homo sapiens)

Image does not exist
Cytokines and inflammatory response
Avoiding immune destruction

Interferon type I signaling (Homo sapiens)

Image does not exist
Interferon type I signaling
Therapeutics

Imatinib and chronic myeloid leukemia (Homo sapiens)

Image does not exist
Imatinib and chronic myeloid leukemia
Personal tools